QualityStocksNewsBreaks Archives - Page 2 of 1518

FridayMar 20, 2026 10:00 am

QualityStocksNewsBreaks – Black Hawk Acquisition Corporation (Nasdaq: BKHA) SPAC Target Vesicor Therapeutics Names Michael Tolentino CEO

Black Hawk Acquisition (Nasdaq: BKHA, BKHAU, BKHAR) announced that its proposed de-SPAC acquisition target, Vesicor Therapeutics Inc., has appointed Michael Tolentino, M.D., as chief executive officer effective March 17, 2026, succeeding founder Luo Feng, Ph.D., who will transition to chief scientific officer as the company advances its p53-based cancer therapeutic platform and prepares for IND-enabling studies and a planned FDA submission. Dr. Tolentino brings more than 20 years of biotechnology leadership experience spanning drug discovery, clinical development and company building, including roles in the development of Avastin and leadership positions at multiple biotech firms, and is expected to support execution of Vesicor growth strategy and progression toward…

FridayMar 20, 2026 9:40 am

QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Signs Strategic Cooperation Agreement With BonV Aero To Expand Counter-UAS Presence In India

ParaZero Technologies (NASDAQ: PRZO) announced the signing of a strategic cooperation agreement with India-based BonV Aero to market its portfolio of counter-UAS solutions, led by the DefendAir system, a mobile, net-based interception platform designed for rapid deployment against hostile drones, while also enabling future configurations and integrations. The companies have already conducted a live demonstration of the portable DefendAir launcher for a key security entity in India, validating its real-world effectiveness and positioning ParaZero to expand its presence in a strategically important market as it explores additional collaboration opportunities across counter-drone applications. To view the full press release, visit https://ibn.fm/maAxq…

ThursdayMar 19, 2026 11:16 am

QualityStocksNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) Highlights New Craigmont Thesis Supporting Porphyry Potential

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising. Nicola Mining (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) reported results from a University of British Columbia M.Sc. thesis on its New Craigmont copper project, which redefines the historical Craigmont deposit as a porphyry-linked skarn system and identifies geochemical and alteration indicators supporting the presence of a nearby porphyry center, reinforcing the company’s exploration model and narrowing target areas to West Craigmont and zones east of the historical mine as it advances toward its 2026 exploration program. To view the full press release, visit https://ibn.fm/qLorA About Nicola Mining Nicola Mining Inc. is…

ThursdayMar 19, 2026 10:45 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Highlights HyBryte Clinical Data In Peer-Reviewed Journal Publication

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced that a comprehensive summary of clinical trials evaluating HyBryte(TM) (synthetic hypericin) for cutaneous T-cell lymphoma has been published in the peer-reviewed journal Expert Opinion on Investigational Drugs, highlighting the therapy’s safety profile, non-mutagenic mechanism and demonstrated efficacy across studies, while supporting its potential as a first-line treatment option as the company advances its ongoing FLASH2 Phase 3 trial with interim analysis expected in the second quarter of 2026. To view the full press release, visit https://ibn.fm/Dbadc About Soligenix Inc. Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is…

ThursdayMar 19, 2026 10:33 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured On BioMedWire Podcast Highlighting Phase 3 HyBryte Progress And Key Inflection Points

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, was featured in the latest BioMedWire Podcast episode where CEO Christopher Schaber discussed the upcoming interim analysis of the Phase 3 FLASH2 study evaluating HyBryte(TM) for cutaneous T-cell lymphoma, noting strong blinded aggregate response rates above initial assumptions and outlining potential outcomes including early study completion or continued enrollment, while emphasizing upcoming interim and top-line data as potentially transformational milestones supporting commercialization and partnership opportunities. To view the full press release, visit https://ibn.fm/ETv8p About Soligenix Inc. Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.…

ThursdayMar 19, 2026 10:20 am

QualityStocksNewsBreaks – Research Solutions, Inc. (NASDAQ: RSSS) To Participate In 38th Annual Roth Conference With Investor Meetings

Research Solutions (NASDAQ: RSSS), a provider of software and AI solutions for enterprise R&D teams and academic institutions, announced its participation in the 38th Annual Roth Conference, taking place March 22-24, 2026, in Dana Point, California, where members of its executive management team will host one-on-one and small group investor meetings and provide early previews of its new agentic research toolkit. To view the full press release, visit https://ibn.fm/t1rhC About ROTH ROTH is a relationship-driven investment bank focused on serving growth companies and their investors. Their full-service platform provides capital raising, high-impact equity research, macroeconomics, sales and trading, technical insights,…

ThursdayMar 19, 2026 9:40 am

QualityStocksNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Repurchases Shares In $27.4M Transaction To Increase SOL-Per-Share

Forward Industries (NASDAQ: FWDI), the leading Solana treasury company, announced it has entered into a privately negotiated agreement to repurchase 6,164,324 shares for $27.4 million, reducing shares outstanding and increasing SOL-per-share to 0.0662 following the transaction, which is being financed through a $40 million digital currency loan agreement with Galaxy Digital secured by treasury assets while allowing the company to continue earning staking rewards, alongside a broader cost reduction plan expected to lower SG&A expenses by approximately 45% by fiscal Q3 as part of efforts to improve operating efficiency and enhance long-term shareholder value. To view the full press release,…

ThursdayMar 19, 2026 9:30 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Issues Invoice For UAE Deployment Of GPS-Denied Navigation Platform

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0), a defense technology company developing GPS-denied navigation and target acquisition solutions, announced it has issued an invoice to a group working closely with the UAE Ministry of Defence for annual software licenses tied to its mobile tactical navigation and targeting platform, with devices to be configured, shipped and deployed for field evaluation, as rising GNSS jamming and spoofing across the Middle East drive demand for its offline-capable solution that integrates ML-enhanced sensor fusion for navigation and…

ThursdayMar 19, 2026 9:00 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Signs Definitive Agreement To Acquire NYIAX, Expanding Institutional-Grade Exchange Infrastructure

Datavault AI (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced it has signed a definitive agreement to acquire NYIAX Inc., adding NYIAX’s intellectual property portfolio and blockchain-powered trading platform to support Datavault AI’s planned rollout of specialized exchanges, including its Information Data Exchange(R), while combining AI-driven valuation, smart contracts, compliant liquidity mechanisms and institutional-grade market infrastructure across data, advertising, critical materials, political inventory and athlete NIL assets. To view the full press release, visit https://ibn.fm/HQhb2 About Datavault AI Datavault AI(TM) (Nasdaq:DVLT) leads AI-driven data experiences, valuation, and monetization in the Web 3.0…

WednesdayMar 18, 2026 10:49 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line

Nutriband (NASDAQ: NTRB) announced that the Costa Rica Ministry of Health has approved its line of kinesiology tapes for import and sale, with exclusive distribution partner Innomedica CCB overseeing and financing the regulatory process. The company plans to ramp up marketing efforts in partnership with Innomedica, targeting both its kinesiology tape products and mosquito repellent patch line following the approval. To view the full press release, visit https://ibn.fm/CJqLZ About Nutriband Inc. We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA(TM) abuse-deterrent technology. AVERSA(TM) technology can be incorporated into any transdermal…

Site Search

Company Search

Category: QualityStocksNewsBreaks